At EyeYon Medical, we are inventing a clearer future
EyeYon Medical develops solutions to heal corneas. We are positioned at the forefront of ophthalmology. Our innovative technologies are targeted to preserve the vision of millions of patients worldwide.
EndoArt®: The future of
corneal transplants
EndoArt® is the first synthetic implant to treat corneal edema and save vision. We are breaking the barriers for corneas, the most common organ transplant worldwide.
Hyper-CL™: Design to deliver
Hyper-CL™ therapeutic contact lens provides a novel solution for the treatment of corneal conditions, increasing bioavailability of any topical drop.
Prof. Gerd U. Auffarth
Heidelberg MC, Germany
Prof. Merab Dvali
Tbilisi State Medical University, Georgia
Dr. Naftali Modi
Rambam MC, Haifa, Israel
Dr Sunita Chaurasia
LV Prasad Eye Institute Hyderabad, India
Prof. Irit Barequet, MD
Sheba Medical Center, Israel
Prof. Francis Mah, MD
San Diego, CA, USA
Prof. Lional Raj, MD
Tirunelveli, India
Dr Boris Knyazer MD, Soroka
Soroka Medical Center
Dr. Moshe Mendelson,
Silicon Valley Eye Physicians
Dr. Navneet Toshniwal,
Dr. Nitin Toshniwal’s Navneet Hospital & Vaccination Centre
The EndoArt could provide a paradigm shift in the treatment of patients with endothelial failure while eliminating the need for human donor tissue.
I’m grateful…to take first steps towards eliminating the global shortage of corneal tissue
The EndoArt® is a critical step forward as the ideal solution for the problem of corneal failure as an “on the shelf” solution for almost every ophthalmic surgeon, not only corneal specialist.
The introduction of EndoArt, which serves as an artificial layer reducing the fluid transfer from the aqueous to the corneal stroma, is a huge step forward.
The proportion of patients achieving a significant improvement in CCT and BCVA was greater in the therapeutic Hyper-CL™ group. In addition, the therapeutic Hyper-CL™ group had a greater improvement in mean BCVA and mean CCT.
I was able to try the Hyper-CL™ in a patient with a corneal melt, significant corneal edema, and Serratia infectious keratitis. The result was dramatic. The patient had resolution within a week with complete resolution of the patient’s AC inflammation/hypopyon. The epithelium was completely healed, and the infiltrate was almost completely resolved. Usually, these are long courses that take an average of 2 weeks to resolve.
The concept of using a novel drug repository contact lens is effective in prolonging corneal antimicrobial availability and drug contact time over the lesion and has demonstrated faster corneal healing, which may affect the overall outcomes in bacterial keratitis. Using a drug depo contact lens, may reduce the regimen of antibiotics, decrease treatment burden on the medical staff, improve patient tolerance, and reduce toxicities.
Upon Hyper CL™ insertion, as well as hyperosmotic saline application, patients were extremely surprised to find a significant sight improvement, emphasizing the high level of excitement and significance those patients were experiencing.
Excellent results for our first patient. Patient and I satisfied with outcome. His Visual acuity improved from 20/200- to 20/60+.
I used lens for bullous keratopathy with excellent result. Corneal condition improves and then visual acuity too. I am excited to use more.
Latest News
EndoArt® in The News! 91-year-old is first patient in England to get an artificial cornea.
EyeYon is proud to have been featured in the mainstream UK/Global media following the first EndoArt surgery in England, at Frimley Health NHS Foundation Trust.
Mr Farley, who received the EndoArt® surgery, said, “It has made a great difference to my sight. It was very blurred and I couldn’t distinguish a face. Now I can see better with it, the brighter the light the better.”
This recognition is a huge achievement for EndoArt®. Many thanks to Mr. Tom Poole and his team for making it possible.
Read the full article here
APACRS 2024
EyeYon Medical will be attending the upcoming Asia-Pacific Association of Cataract & Refractive Surgeons (APACRS) event in Chengdu, China from 30th May- 1st June.
Prof. Jing Hong & Prof. Chen Wei will be providing presentations and Dr Ofer Daphnah, Limor Leifenberg Kuznits, Nahum Ferera, Zhao XinShan & Han Pengxiang will be attending the event. We look forward to seeing you there.
Check out the latest news
Check out our recent events!
Read the latest publications